Hydrogenology
Hydrogenology editorial study record

Hydrogen-rich saline promotes recovery of renal function after ischemia-reperfusion injury in rats via anti-apoptosis and anti-inflammation

Li Y et al. · Front Pharmacol. 2016;7:106.

PreclinicalOther formsPublished 2016
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled rat unilateral-renal-ischemia experiment comparing short and continuous H₂-saline schedules

Research topic

Kidney and urinary health

Administration classification

Other forms

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Rats after right nephrectomy and 45-minute left renal-pedicle occlusion

Sample

120 rats: sham n=30, ischemia/reperfusion n=30, continuous H₂-saline n=30 and 24-hour H₂-saline n=30

Duration

Short 24-hour treatment or continuous treatment through 108 hours

Intervention

0.6 mmol/L hydrogen-rich saline, 1 mL/kg intraperitoneally immediately after reperfusion and every 4 hours

Hydrogen form

H₂ dissolved in saline — H₂ only, not Brown’s gas and not inhalation.

H₂ specification

0.6 mmol/L dissolved H₂; saline was saturated for 6 hours at 0.4 MPa and verified by gas chromatography.

H₂ flow

Not applicable — intraperitoneal saline, not gas inhalation.

O₂ delivered with H₂

No O₂ was co-delivered as part of the intervention.

Comparator

Ischemia-reperfusion rats receiving ordinary saline and sham-operated controls

Reported, not endorsed

Outcomes and reported result

Outcomes measured

BUN, creatinine, histology, apoptosis and Bcl-2, Bax, caspases, IL-6 and TNF-α

Reported result

The article reports less histologic injury and faster BUN and creatinine recovery with H₂ saline. Renal-function measures worsened again after the short treatment was stopped compared with continuous treatment.

Results-extraction completeness

The complete open-access article was checked for preparation, concentration, allocation, dose, schedules and principal positive and null results.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Preclinical renal-ischemia model with nephrectomy, frequent injections and multiple time points. The article contains internally confusing wording about Bcl-2/Bax direction that requires independent verification.

Applies directly to

Renal ischemia-reperfusion after contralateral nephrectomy in rats.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 27148060 · DOI: 10.3389/fphar.2016.00106

Publisher access

Open-access full text is available through PMC and Frontiers.

Extraction basis

Open-access PMC/Frontiers full text and PubMed record.

Record revision

2026-08-10